Cellular factors associated with latency and spontaneous Epstein-Barr virus reactivation in B-lymphoblastoid cell lines. (Q39740136)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20153012%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

title

Cellular factors associated with latency and spontaneous Epstein-Barr virus reactivation in B-lymphoblastoid cell lines (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20153012%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

0 references

Michael L Davies

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20153012%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Shushen Xu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20153012%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Steven A Webber

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20153012%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Laura R Wasil

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20153012%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Diana Metes

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20153012%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

David T Rowe

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20153012%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

language of work or name

English

0 references

publication date

11 February 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20153012%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20153012%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

400

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20153012%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20153012%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

53-67

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20153012%20AND%20SRC:MED&resulttype=core&format=json

Immunodominance of lytic cycle antigens in Epstein-Barr virus-specific CD4+ T cell preparations for therapy

18 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.002

Control of Epstein-Barr virus reactivation by activated CD40 and viral latent membrane protein 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.002

Bruton's tyrosine kinase is involved in miR-346-related regulation of IL-18 release by lipopolysaccharide-activated rheumatoid fibroblast-like synoviocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.002

Evidence for genetic susceptibility towards development of posttransplant lymphoproliferative disorder in solid organ recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.002

Interferon and granulopoiesis signatures in systemic lupus erythematosus blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.002

X-box-binding protein 1 activates lytic Epstein-Barr virus gene expression in combination with protein kinase D.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.002

The presence of IFNG 3/3 genotype in the recipient associates with increased risk for Epstein-Barr virus reactivation after allogeneic haematopoietic stem cell transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.002

Cytotoxic T lymphocyte therapy for Epstein-Barr virus+ Hodgkin's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.002

Altered cellular mRNA levels in human cytomegalovirus-infected fibroblasts: viral block to the accumulation of antiviral mRNAs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.002

Role of NF-kappa B in cell survival and transcription of latent membrane protein 1-expressing or Epstein-Barr virus latency III-infected cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.002

Epstein-barr virus-induced changes in B-lymphocyte gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.002

Induction of the early growth response 1 gene by Epstein-Barr virus lytic transactivator Zta.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.002

EBNA-3B- and EBNA-3C-regulated cellular genes in Epstein-Barr virus-immortalized lymphoblastoid cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.002

Histone hyperacetylation occurs on promoters of lytic cycle regulatory genes in Epstein-Barr virus-infected cell lines which are refractory to disruption of latency by histone deacetylase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.002

Gene profiling of a myeloma cell line reveals similarities and unique signatures among IL-6 response, N-ras-activating mutations, and coculture with bone marrow stromal cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.002

IFN-gamma gene polymorphisms associate with development of EBV+ lymphoproliferative disease in hu PBL-SCID mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.002

B lymphocytes and Epstein-Barr virus: the lesson of post-transplant lymphoproliferative disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.002

Biologically relevant phenotypic changes and enhanced growth properties induced in B lymphocytes by an EBV strain derived from a histologically aggressive Hodgkin's disease

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.002

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.002

inferred from DOI database lookup

7 January 2021

based on heuristic

Sensitivity of Epstein-Barr virus-induced B cell tumor to apoptosis mediated by anti-CD95/Apo-1/fas antibody

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.002

Variable methylation of the Epstein-Barr virus Wp EBNA gene promoter in B-lymphoblastoid cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.002

Epstein-Barr virus (EBV) latent membrane protein 2A regulates B-cell receptor-induced apoptosis and EBV reactivation through tyrosine phosphorylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.002

Epstein-Barr virus latent membrane protein 1 trans-activates miR-155 transcription through the NF-kappaB pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.002

Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.002

Molecular characterization of early human T/NK and B-lymphoid progenitor cells in umbilical cord blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.002

Association of transforming growth factor-beta1 gene polymorphism in the development of Epstein-Barr virus-related hematologic diseases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.002

Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.002

Differential transactivation by the p53 transcription factor is highly dependent on p53 level and promoter target sequence.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.002

Herpesvirus infections in organ transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.002

Ets-1 regulates plasma cell differentiation by interfering with the activity of the transcription factor Blimp-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.002

The lytic cycle of Epstein-Barr virus is associated with decreased expression of cell surface major histocompatibility complex class I and class II molecules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.002

CD4+ T cell-induced differentiation of EBV-transformed lymphoblastoid cells is associated with diminished recognition by EBV-specific CD8+ cytotoxic T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.002

Accumulation of specific RNAs encoding transcriptional factors and stress response proteins against a background of severe depletion of cellular RNAs in cells infected with herpes simplex virus 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.002

Gene expression profile analysis of AIDS-related primary effusion lymphoma (PEL) suggests a plasmablastic derivation and identifies PEL-specific transcripts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.002

Lack of BIC and microRNA miR-155 expression in primary cases of Burkitt lymphoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.002

MicroRNA-155 is regulated by the transforming growth factor beta/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.002

MicroRNAs 221 and 222 target p27Kip1 in Marek's disease virus-transformed tumour cell line MSB-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.002

Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.002

The LMP1 oncogene of EBV activates PERK and the unfolded protein response to drive its own synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.002

The unfolded protein response and autophagy: herpesviruses rule!

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.002

Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.002

Cytotoxic drug sensitivity of Epstein-Barr virus transformed lymphoblastoid B-cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.002

CD40 stimulation induces Pax5/BSAP and EBF activation through a APE/Ref-1-dependent redox mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.002

Epstein-Barr virus-encoded LMP1 induces a hyperproliferative and inflammatory gene expression programme in cultured keratinocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.002

Human B cells immortalized with Epstein-Barr virus upregulate CCR6 and CCR10 and downregulate CXCR4 and CXCR5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.002

Cutting edge: profile of chemokine receptor expression on human plasma cells accounts for their efficient recruitment to target tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.002

Host gene induction and transcriptional reprogramming in Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8)-infected endothelial, fibroblast, and B cells: insights into modulation events early during infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.002

The human leukocyte antigen class I region is associated with EBV-positive Hodgkin's lymphoma: HLA-A and HLA complex group 9 are putative candidate genes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.002

The transcriptional regulation of B cell lineage commitment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.002

Inositol phosphatase SHIP1 is a primary target of miR-155

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.002

caGEDA: a web application for the integrated analysis of global gene expression patterns in cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.002

Epstein-Barr virus LMP2A interferes with global transcription factor regulation when expressed during B-lymphocyte development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.002

Plasmacytoid differentiation of Epstein-Barr virus-transformed B cells in vivo is associated with reduced expression of viral latent genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.002

Clonal evolution of lymphoblastoid cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.002

Epstein-Barr virus latent membrane protein 2A mimics B-cell receptor-dependent virus reactivation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.002

Direct B/B-cell interactions in immunoglobulin synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.002

Cell target genes of Epstein-Barr virus transcription factor EBNA-2: induction of the p55alpha regulatory subunit of PI3-kinase and its role in survival of EREB2.5 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.002

Epstein-Barr virus-encoded LMP2A regulates viral and cellular gene expression by modulation of the NF-kappaB transcription factor pathway.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.002

Dendritic cells expand Epstein Barr virus specific CD8+ T cell responses more efficiently than EBV transformed B cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.002

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.002

Steps involved in immortalization and tumorigenesis in human B-lymphoblastoid cell lines transformed by Epstein-Barr virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.002

Plasma cell-specific transcription factor XBP-1s binds to and transactivates the Epstein-Barr virus BZLF1 promoter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.002

Epstein-Barr virus LMP2A enhances B-cell responses in vivo and in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.002

In vitro establishment of tumorigenic human B-lymphoblastoid cell lines transformed by Epstein-Barr virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.002

Gene expression profiling of plasma cells and plasmablasts: toward a better understanding of the late stages of B-cell differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.002

Shhh! Silencing by microRNA-155

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.002

Ebf1-mediated down-regulation of Id2 and Id3 is essential for specification of the B cell lineage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.002

Persistence of the Epstein-Barr virus and the origins of associated lymphomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.002

Transforming growth factor {beta} (TGF-{beta})-Smad target gene protein tyrosine phosphatase receptor type kappa is required for TGF-{beta} function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.002

EBV-transformed lymphoblastoid cell lines down-regulate EBNA in parallel with secretory differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.002

Cell surface phenotyping and cytokine production of Epstein-Barr Virus (EBV)-transformed lymphoblastoid cell lines (LCLs).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.002

Transcriptional regulation during p21WAF1/CIP1-induced apoptosis in human ovarian cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.002

Receptor-type protein-tyrosine phosphatase-kappa regulates epidermal growth factor receptor function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.002

MicroRNA-155 is an Epstein-Barr virus-induced gene that modulates Epstein-Barr virus-regulated gene expression pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.002

XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.002

Epstein-Barr virus nuclear antigen (EBNA) 3A induces the expression of and interacts with a subset of chaperones and co-chaperones.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.002

Virus and cell RNAs expressed during Epstein-Barr virus replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.002

The molecular classification of multiple myeloma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.002

The HapMap Resource is Providing New Insights into Ourselves and its Application to Pharmacogenomics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.002

RNAs induced by Epstein-Barr virus nuclear antigen 2 in lymphoblastoid cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.002

A functional MicroRNA-155 ortholog encoded by the oncogenic Marek's disease virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.002

Cellular gene expression altered by human cytomegalovirus: global monitoring with oligonucleotide arrays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.002